BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8340136)

  • 1. [The role of cytokines in endotoxic shock and in endotoxin hypersensitivity].
    Freudenberg MA; Ness T; Kumazawa Y; Galanos C
    Immun Infekt; 1993 Apr; 21(2):40-4. PubMed ID: 8340136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of endotoxin shock and endotoxin hypersensitivity.
    Galanos C; Freudenberg MA
    Immunobiology; 1993 Apr; 187(3-5):346-56. PubMed ID: 8330903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma is a master regulator of endotoxin shock syndrome in mice primed with heat-killed Propionibacterium acnes.
    Kawa K; Tsutsui H; Uchiyama R; Kato J; Matsui K; Iwakura Y; Matsumoto T; Nakanishi K
    Int Immunol; 2010 Mar; 22(3):157-66. PubMed ID: 20130231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity to endotoxin and mechanisms of host-response.
    Galanos C; Freudenberg MA; Matsuura M; Coumbos A
    Prog Clin Biol Res; 1988; 272():295-308. PubMed ID: 3393569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.
    Wysocka M; Kubin M; Vieira LQ; Ozmen L; Garotta G; Scott P; Trinchieri G
    Eur J Immunol; 1995 Mar; 25(3):672-6. PubMed ID: 7705395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.
    Lamping N; Dettmer R; Schröder NW; Pfeil D; Hallatschek W; Burger R; Schumann RR
    J Clin Invest; 1998 May; 101(10):2065-71. PubMed ID: 9593762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS.
    Mathison JC; Tobias PS; Wolfson E; Ulevitch RJ
    J Immunol; 1992 Jul; 149(1):200-6. PubMed ID: 1607653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant factor C competes against LBP to bind lipopolysaccharide and neutralizes the endotoxicity.
    Li P; Ho B; Ding JL
    J Endotoxin Res; 2007; 13(3):150-7. PubMed ID: 17621557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interferons in LPS hypersensitivity.
    Freudenberg MA; Kalis C; Chvatchko Y; Merlin T; Gumenscheimer M; Galanos C
    J Endotoxin Res; 2003; 9(5):308-12. PubMed ID: 14577847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory mechanisms of host responsiveness to endotoxin (lipopolysaccharide).
    Mathison J; Tobias P; Wolfson E; Ulevitch R
    Pathobiology; 1991; 59(3):185-8. PubMed ID: 1883513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice.
    Tsutsui H; Matsui K; Kawada N; Hyodo Y; Hayashi N; Okamura H; Higashino K; Nakanishi K
    J Immunol; 1997 Oct; 159(8):3961-7. PubMed ID: 9378984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.
    Doherty GM; Lange JR; Langstein HN; Alexander HR; Buresh CM; Norton JA
    J Immunol; 1992 Sep; 149(5):1666-70. PubMed ID: 1506688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine defence in endotoxin shock (a review).
    Berczi I
    Acta Microbiol Hung; 1993; 40(4):265-302. PubMed ID: 7976206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFIT2 is an effector protein of type I IFN-mediated amplification of lipopolysaccharide (LPS)-induced TNF-α secretion and LPS-induced endotoxin shock.
    Siegfried A; Berchtold S; Manncke B; Deuschle E; Reber J; Ott T; Weber M; Kalinke U; Hofer MJ; Hatesuer B; Schughart K; Gailus-Durner V; Fuchs H; Hrabe de Angelis M; Weber F; Hornef MW; Autenrieth IB; Bohn E
    J Immunol; 2013 Oct; 191(7):3913-21. PubMed ID: 24014876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage.
    Bochkov VN; Kadl A; Huber J; Gruber F; Binder BR; Leitinger N
    Nature; 2002 Sep; 419(6902):77-81. PubMed ID: 12214235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin.
    Ulevitch RJ; Tobias PS
    Annu Rev Immunol; 1995; 13():437-57. PubMed ID: 7542010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of IFN-gamma in the pathology of experimental endotoxemia.
    Heinzel FP
    J Immunol; 1990 Nov; 145(9):2920-4. PubMed ID: 2120341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-associated differences in TNF-alpha and nitric oxide production in endotoxic mice.
    Chorinchath BB; Kong LY; Mao L; McCallum RE
    J Immunol; 1996 Feb; 156(4):1525-30. PubMed ID: 8568256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.